EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Adjuvant Therapy: Melanoma

Diwakar Davar, Ahmad Tarhini, John M Kirkwood

Journal of Skin Cancer · 2011

DOI: 10.1155/2011/274382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Skin Cancer, 2011. Verfasst von Diwakar Davar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With an incidence that is increasing at 2–5% per year, cutaneous melanoma is an international scourge that disproportionately targets young individuals. Despite much research, the treatment of advanced disease is still quite challenging. Immunotherapy with high-dose interferon- α 2b or interleukin-2 benefits a select group of patients in the adjuvant and metastatic settings, respectively, with significant attendant toxicity. Advances in the biology of malignant melanoma and the role of immunomodulatory therapy have produced advances that have stunned the field. In this paper, we review the data for the use of interferon- α 2b in various dosing ranges, vaccine therapy, and the role of radiotherapy in the adjuvant setting for malignant melanoma. Recent trials in the metastatic setting using anticytoxic T-lymphocyte antigen-4 (anti-CTLA-4) monoclonal antibody therapy and BRAF inhibitor therapy have demonstrated clear benefit with prolongation of survival. Trials investigating combinations of these novel agents with existing immunomodulators are at present underway.

Autor:innen und Institutionen

  • Division of General Internal Medicine, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA.

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Davar, D., Tarhini, A., & Kirkwood, J. M. (2011). Adjuvant Therapy: Melanoma. Journal of Skin Cancer. https://doi.org/10.1155/2011/274382

Vancouver

Davar D, Tarhini A, Kirkwood JM. Adjuvant Therapy: Melanoma. Journal of Skin Cancer. 2011. doi:10.1155/2011/274382

BibTeX
@article{Davar2011,
  author = {Davar, Diwakar and Tarhini, Ahmad and Kirkwood, John M},
  title = {Adjuvant Therapy: Melanoma},
  journal = {Journal of Skin Cancer},
  year = {2011},
  doi = {10.1155/2011/274382}
}
Kostenlos starten →